# Study of TRIFLURIDINE/TIPIRACIL in Previously Treated Cholangiocarcinoma

> **NCT04076761** · PHASE2 · TERMINATED · sponsor: **Sunnybrook Health Sciences Centre** · enrollment: 8 (actual)

## Conditions studied

- Cholangiocarcinoma
- Bile Duct Cancer

## Interventions

- **DRUG:** Trifluridine/Tipiracil

## Key facts

- **NCT ID:** NCT04076761
- **Lead sponsor:** Sunnybrook Health Sciences Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-12-11
- **Primary completion:** 2022-09-30
- **Final completion:** 2022-09-30
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Lack of Funding
- **Last updated:** 2022-12-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04076761

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04076761, "Study of TRIFLURIDINE/TIPIRACIL in Previously Treated Cholangiocarcinoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04076761. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*